First, the integrative copy-number aberration and gene expression analyses indicated that AZIN1 gene expression increased in a focal amplification of 8q22.3 and associated with metastatic recurrence [78], which identified AZIN1 as a novel driver of metastatic progression in high-risk prostate cancer. The gene discussed is AZIN1; the disease is prostate carcinoma.